Show simple item record

dc.contributor.editorSumiyoshi, Tomiki
dc.date.accessioned2022-02-24T10:35:57Z
dc.date.available2022-02-24T10:35:57Z
dc.date.issued2022
dc.identifierONIX_20220224_9783036528588_70
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/78772
dc.description.abstractSchizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otherfirst-episode psychosis
dc.subject.othermetacognitive training
dc.subject.othercognitive insight
dc.subject.othersessions
dc.subject.otherexperiment
dc.subject.othermagnetic resonance imaging
dc.subject.otherschizophrenia
dc.subject.otherschizotypal disorder
dc.subject.othergyrification
dc.subject.othersuperior temporal gyrus
dc.subject.otherneurodevelopment
dc.subject.othercannabis
dc.subject.otherproteomics
dc.subject.otherolfactory neuroepithelium
dc.subject.othermetabolism
dc.subject.otherRNA
dc.subject.otherZNF326
dc.subject.otherMTREX
dc.subject.otherantipsychotics
dc.subject.otherbody mass index
dc.subject.otherweight gain
dc.subject.othermetabolic syndrome
dc.subject.otherserotonin
dc.subject.othergenes
dc.subject.otherpharmacogenetics
dc.subject.othermental disorders
dc.subject.otherdevelopmental disorders
dc.subject.othersocial cognition
dc.subject.othersocial function
dc.subject.otherfacial expression recognition
dc.subject.othertest battery
dc.subject.otherquality of life
dc.subject.othersystematic review
dc.subject.otherneeds survey
dc.subject.otherneuromodulation
dc.subject.othertranscranial direct current stimulation (tDCS)
dc.subject.othersuperior temporal sulcus
dc.subject.otherP300
dc.subject.otherevent-related potentials
dc.subject.otherclinical high-risk
dc.subject.otherpsychosis
dc.subject.otherat risk mental state
dc.subject.othercognition
dc.subject.otherlatency
dc.subject.othermicroglia
dc.subject.othersynaptic pruning
dc.subject.othercomplement
dc.subject.otherCX3CR1
dc.subject.othermedication
dc.subject.otherdiagnosis
dc.subject.otherpiccolo
dc.subject.otherpresynaptic cytomatrix protein
dc.subject.othermedial prefrontal cortex
dc.subject.otherdorsal striatum
dc.subject.otheroptogenetics
dc.subject.othersocial functioning
dc.subject.othern/a
dc.titlePsychoneurobiology Research and Personalized Treatment of Schizophrenia
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-2858-8
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036528588
oapen.relation.isbn9783036528595
oapen.pages133
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/